Literature DB >> 6603978

T cell subsets and Langerhans cells in skin tumours.

R Fernandez-Bussy, F Cambazard, G Mauduit, D Schmitt, J Thivolet.   

Abstract

The purpose of this study was to examine the phenotype of the cutaneous immunocompetent cells and Langerhans cells in malignant and benign tumour infiltrates (basal cell and squamous cell carcinomas, malignant melanoma, seborrheic keratosis and naevus) by the use of monoclonal antibodies directed against T cell populations and Langerhans cells. This in situ investigation indicates that the lymphocytes participating in the inflammatory reaction around skin tumours are mainly of the cytotoxic/suppressor class. It suggests, moreover, that interaction occurs in the skin between T lymphocytes and HLA-DR suppressing cells. The in situ study of the inflammatory immune response should be a useful complement to in vitro investigations in the exploration of immune reaction against tumours of the skin.

Entities:  

Mesh:

Year:  1983        PMID: 6603978     DOI: 10.1016/0277-5379(83)90056-1

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  4 in total

1.  Detection of S-100 labelled cells in nasopharyngeal carcinoma.

Authors:  L Lauriola; F Michetti; S Sentinelli; D Cocchia
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

2.  Macrophages in melanocytic naevi.

Authors:  E B Bröcker; C Reckenfeld; H Hamm; D J Ruiter; C Sorg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 3.  Langerhans cells and their role in oral mucosal diseases.

Authors:  Juhi Upadhyay; Ram B Upadhyay; Pankaj Agrawal; Shweta Jaitley; Rhitu Shekhar
Journal:  N Am J Med Sci       Date:  2013-09

4.  Do Langerhans cells play a role in vulvar epithelium resistance to squamous cell carcinoma?

Authors:  Helena Rotsztejn; Ewa Trznadel-Budźko; Dorota Jesionek-Kupnicka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-03-20       Impact factor: 4.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.